Find link

language:

Find link is a tool written by Edward Betts.

Longer titles found: Favezelimab/pembrolizumab (view)

searching for pembrolizumab 29 found (140 total)

Chordoma (2,179 words) [view diff] exact match in snippet view article find links to article

response rate with median progression free survival of 10.5 months Pembrolizumab: 12% objective response rate with median progression free survival of

Toni Choueiri (1,497 words) [view diff] exact match in snippet view article find links to article

with Robert Motzer the development of the combination of Lenvatinib+pembrolizumab which was FDA approved in August 2021. Later that year, Choueiri presented

GPER (4,250 words) [view diff] exact match in snippet view article find links to article

monotherapy and in combination with the immune checkpoint inhibitor, pembrolizumab, for the treatment of multiple solid tumor malignancies. Activation

Salivary gland–like carcinoma of the lung (620 words) [view diff] exact match in snippet view article find links to article

Yumiko; Kuyama, Shoichi (2021-08-08). "Carboplatin, pemetrexed, and pembrolizumab was effective for primary salivary gland‐type lung adenocarcinoma diagnosed

Kidney cancer (4,786 words) [view diff] exact match in snippet view article find links to article

cell RCC tumor characteristics and having undergone treatment with Pembrolizumab for 17 cycles (around 1 year) had significant improvement in disease-free

Acral lentiginous melanoma (1,258 words) [view diff] exact match in snippet view article find links to article

metastatic melanoma include the biologic immunotherapy agents ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such as vemurafenib and dabrafenib;

Institute for Safe Medication Practices (616 words) [view diff] exact match in snippet view article find links to article

Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes". Hospital Pharmacy. 54 (4): 241–245. doi:10

Toll-like receptor 4 (9,082 words) [view diff] exact match in snippet view article find links to article

and potent adjuvant activity in phase 2 trials in combination with pembrolizumab in patients with follicular lymphoma. Besides the recognized anti-tumor

Interstitial nephritis (2,303 words) [view diff] exact match in snippet view article find links to article

(e.g. sunitinib), checkpoint inhibitors (e.g. ipilimumab, nivolumab, pembrolizumab, atezolizumab) Contrast agent Gadolininum based contrast agent Other

RAR-related orphan receptor gamma (2,372 words) [view diff] exact match in snippet view article find links to article

Study of Novel Immuno-Oncology Candidate LYC-55716 in Combination with Pembrolizumab". January 2018. orphan+nuclear+receptor+ROR-gamma at the U.S. National

Anaplastic thyroid cancer (2,157 words) [view diff] exact match in snippet view article find links to article

demonstrating promising effects. Specific drugs being tested are atezolizumab, pembrolizumab, and spartalizumab, amongst others. Combinatorial therapy that is molecular-based

Richard Gaynor (1,724 words) [view diff] exact match in snippet view article find links to article

The Combination Of Lilly's ALIMTA (pemetrexed) And Merck's KEYTRUD (pembrolizumab) Show A Near-Doubling Of Objective Response Rate Compared To Standard

Transgene (company) (1,178 words) [view diff] exact match in snippet view article

for "A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors" at ClinicalTrials.gov "Regulatory

Roy S. Herbst (1,334 words) [view diff] exact match in snippet view article find links to article

Retrieved 2021-03-10. "Clinical Research Forum Awards, April 2015" (PDF). "Pembrolizumab confers sustained OS benefit in PD-L1-expressing non-small cell lung

TME Pharma (486 words) [view diff] exact match in snippet view article find links to article

NCT03168139 for "Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer" at ClinicalTrials.gov Clinical

Viralytics (2,428 words) [view diff] case mismatch in snippet view article find links to article

another checkpoint inhibitor, in metastatic melanoma. CAPRA (CAvatak and PembRolizumab in Advanced Melanoma). This Phase I study (ClinicalTrials.gov identifier

MRNA-5671 (116 words) [view diff] exact match in snippet view article find links to article

trial number NCT03948763 for "A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)" at ClinicalTrials.gov v t e

Cora Sternberg (3,310 words) [view diff] exact match in snippet view article find links to article

patients. She is an author on the practice-changing phase III study of Pembrolizumab as 2nd-line therapy after failure of platinum-based therapy vs. chemotherapy

Hodgkin lymphoma (8,577 words) [view diff] exact match in snippet view article find links to article

cytotoxic component MMAE, and the checkpoint inhibitors, Nivolumab and Pembrolizumab. This has been an important step in the treatment for the few, but still

Hereditary nonpolyposis colorectal cancer (4,902 words) [view diff] exact match in snippet view article find links to article

Mohammed Z.H.; Marinello, Patricia; Diaz, Luis A. (3 December 2020). "Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer". New

DNA mismatch repair (4,179 words) [view diff] exact match in snippet view article find links to article

Evaluation and Research. "Approved Drugs –FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication". www.fda.gov. Retrieved 2017-05-24

Selvigaltin (264 words) [view diff] exact match in snippet view article find links to article

anti-PD-1/anti-PD-L1: GB1211 reverses galectin-3 induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1". Journal of Clinical Oncology

Barbara Burtness (664 words) [view diff] exact match in snippet view article find links to article

the YCC Clinical Science Research Award in recognition of her study "Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent

Boserolimab (265 words) [view diff] exact match in snippet view article find links to article

; Ahn, M-J. (December 2021). "114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line

Chandler Park (2,780 words) [view diff] exact match in snippet view article find links to article

Targeted Oncology. March 31, 2023. Retrieved December 23, 2023. "Adjuvant Pembrolizumab in Patients with Clear-cell Renal Cell Carcinoma". Targeted Oncology

Mutational signatures (4,037 words) [view diff] exact match in snippet view article find links to article

Pazdur R (October 2017). "FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma". Clinical Cancer Research

Immunologic constant of rejection (2,430 words) [view diff] exact match in snippet view article find links to article

cells. An 18-gene Gene Expression Profile that predicted response to pembrolizumab across multiple solid tumors. Can be used with a platform such as the

Paul Billings (3,777 words) [view diff] exact match in snippet view article find links to article

analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab.Nat Cancer 1, 873–881 (2020). https://doi.org/10.1038/s43018-020-0096-5

Guardant Health (2,472 words) [view diff] exact match in snippet view article find links to article

instability-high (MSI-High) solid tumors who may benefit from Keytruda (pembrolizumab) and patients with MSI-High advanced colorectal cancer who may benefit